Antigüedades / Polvo crudo CAS Mk-2866 841205-47-8 a good way to build muscle
Detalle rápido:
CASO 841205-47-8
nombre del producto: Antigüedades,Enobosarm
As: GTx-024,MK-2866
Fórmula molecular: C19H14F3N3O3
Peso molecular: 389.3279696
Pureza: 99%
Apariencia: Polvo blanco
Calificación: As
Descripción:
MK-2866 / Enobosarm / Ostarine es un SARM no esteroideo / modulador selectivo del receptor de andrógenos, que tiene efectos anabólicos selectivos de tejidos en músculos y huesos, sparing other androgenic tissue related to hair growth in female and prostate effects in male. MK-2866 / Enobosarm / Ostarine is one of the most favorable of any bodybuilding SARMS for being the most anabolic.
You can not campare it to anabolic steroids. But in one aspect, you also see none of the side effects you would see with steroids. MK-2866 / Enobosarm / Ostarine was originally prescribed for the treatment and prevention of muscle wasting. Cancer induced muscle wasting begins early in the course of a patient’s malignant disease. when given to the patients, lean muscle mass was observed.
Solicitud:
Selective androgen receptor modulators may be used by athletes to assist in training and increase physical stamina and fitness, potentially producing effects similar to anabolic steroids.
For research.
Antigüedades (MK-2866) is a SARM developed by GTx for the prevention and treatment of muscle wasting. It may eventually be a medical prescription for the prevention of cachexia, atrophy and sarcopenia as well as for Hormone or Replacement Therapy.
As a research chemical, Ostarine belongs to a class of chemicals know as SARMS or selective androgen receptor modulators. SARMS create selective anabolic activity at certain androgen receptors. In comparison to and other anabolic steroids, the advantage of SARMS, is they do not have androgenic activity in non-skeletal muscle tissues. Ostarine is effective in maintaining and increasing lean body mass
Other SARMs
| Nombre |
NO CAS. |
Uso |
| AQUÍ |
2627-69-2 |
acts by entering nucleoside pools, significantly increasing levels of adenosine
during periods of ATP breakdown |
| MK2866 |
841205-47-8 |
medical prescription for prevention of cachexia, atrophy, and sarcopenia and
for Hormone or Testoserone Replacement Therapy. |
| MK-677 |
15972-10-0 |
for the treatment of frailty in the elderly |
| LGD-4033 |
1165910-22-4 |
pharmacological profile similar to that of enobosarm, Antigüedades,MK-2866 |
| GW1516 |
317318-70-0 |
For obesity, diabetes, dyslipidemia and cardiovascular disease |
| Andarine(S4) |
401900-40-0 |
partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
| SR9009 |
1379686-30-2 |
under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of mice |
| RAD140 |
1182367-47-0 |
New generation for gaining mass and cutting edges |
| YK11 |
431579-34-9 |
YK11: a SARM and myostatin inhibitor in one
|
| AC262356 |
870888-46-3 |
New SARMS |
| SR9011 |
1379686-29-9 |
New SARMS |
| S23 |
1010396-29-8 |
New SARMS |
| GW0724 |
317318-84-6 |
New SARMS |
Gerente de ventas